Fighting the enemy: one health approach against microbial resistance
نویسندگان
چکیده
منابع مشابه
Antimicrobial Drugs in Fighting against Antimicrobial Resistance
The outbreak of antimicrobial resistance, together with the lack of newly developed antimicrobial drugs, represents an alarming signal for both human and animal healthcare worldwide. Selection of rational dosage regimens for traditional antimicrobial drugs based on pharmacokinetic/pharmacodynamic principles as well as development of novel antimicrobials targeting new bacterial targets or resist...
متن کاملFighting microbial drug resistance: a primer on the role of evolutionary biology in public health
Although microbes have been evolving resistance to antimicrobials for millennia, the spread of resistance in pathogen populations calls for the development of new drugs and treatment strategies. We propose that successful, long-term resistance management requires a better understanding of how resistance evolves in the first place. This is an opportunity for evolutionary biologists to engage in ...
متن کاملFighting resistance.
A pioneer in the early identification of drug resistance in tuberculosis patients, Sir John Crofton and his colleagues' seminal research into multidrug therapy for tuberculosis patients in the 1950s laid the groundwork for the WHO-recommended tuberculosis treatment today. This is one of the last interviews he gave before he passed away on 3 November at the age of 97, after a career that spanned...
متن کاملCIPARS: A One-Health Approach to Antimicrobial Resistance Surveillance
1Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, Guelph, ON, Canada; 2Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, St Hyacinthe, QC, Canada; 3Centre for Foodborne, Environmental, and Zoonotic Infectious Diseases, Public Health Agency of Canada, Guelph, ON, Canada; 4Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, Saskatoon, SK, Canada; ...
متن کاملColistin in Pig Production: Chemistry, Mechanism of Antibacterial Action, Microbial Resistance Emergence, and One Health Perspectives
Colistin (Polymyxin E) is one of the few cationic antimicrobial peptides commercialized in both human and veterinary medicine. For several years now, colistin has been considered the last line of defense against infections caused by multidrug-resistant Gram-negative such as Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae. Colistin has been extensively used orally sinc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Microbial Biotechnology
سال: 2020
ISSN: 1751-7915,1751-7915
DOI: 10.1111/1751-7915.13587